Expression of interest: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D
Medicine, Pharmacology and Public Health research grant — mandatory expression of interest from Medical Research Council (UKRI)
About
Mandatory expression-of-interest stage for research on medical countermeasures to improve UK preparedness for CBRN incidents. Projects may develop or test therapeutics, diagnostics, medical devices and other interventions through early clinical studies. The programme allows up to GBP4 million per application, funds 80% of full economic cost and supports projects up to 30 months. Submit the required EOI form and the funder-requested email by 20 October 2026 at 16:00 UK time. Invited full applications open on 5 November 2026.
Eligibility
Career stage: Not stated
Institution applies
Host location: United Kingdom
Reviewed Sep 24, 2026. Check the funder’s full conditions before applying.
UK-based research organisations with standard MRC eligibility. One lead application per person. International organisations cannot be project leads, co-leads or partners; eligible UK businesses and non-research charities may participate as partners under the call rules.
Topics
Related funding
Experimental medicine stage one
MRC funding for academically led research using experimental interventions or challenges in humans to investigate mechanisms of disease. Projects should address an important mechanistic question and…
Engineering Biology Collaborative R&D: Round 3
This business-led collaborative research and development competition will fund new engineering-biology products, processes and services and de-risk technologies with strong market potential.…
NERC urgency funding: open
NERC supports urgent environmental research following an unexpected natural event when critical early data would otherwise be lost. Examples include exceptional floods, earthquakes and other…
Source: ukri.org